A federal judge ruled that Roxane Laboratories infringed on two of Vanda Pharmaceuticals Inc.'s (Nasdaq: VNDA) patents. The stock price soared $2.42 to close at $14.17.
Vanda Pharmaceuticals' patents were infringed upon
August 25, 2016 at 19:27 PM EDT